|
GPR173 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.061700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.380600E-03 |
| Normal-vs-Stage2 |
7.156100E-04 |
| Normal-vs-Stage3 |
5.182000E-01 |
| Normal-vs-Stage4 |
1.763810E-01 |
| Stage1-vs-Stage2 |
2.799400E-01 |
| Stage1-vs-Stage3 |
2.076800E-01 |
| Stage1-vs-Stage4 |
1.694180E-02 |
| Stage2-vs-Stage3 |
4.905600E-02 |
| Stage2-vs-Stage4 |
5.116200E-03 |
| Stage3-vs-Stage4 |
1.166620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.798700E-03 |
| Normal-vs-AfricanAmerican |
1.011420E-01 |
| Normal-vs-Asian |
1.547040E-01 |
| Caucasian-vs-AfricanAmerican |
1.289760E-02 |
| Caucasian-vs-Asian |
1.137710E-02 |
| AfricanAmerican-vs-Asian |
4.424800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.861700E-03 |
| Normal-vs-Female |
6.599000E-01 |
| Male-vs-Female |
2.145700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.054800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.344800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.460500E-02 |
| Normal-vs-Age(81-100Yrs) |
8.198300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.614960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.121800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.087700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.482400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.885000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.805600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.478000E-01 |
| Normal-vs-Grade 2 |
9.499900E-03 |
| Normal-vs-Grade 3 |
1.366950E-01 |
| Normal-vs-Grade 4 |
2.176800E-01 |
| Grade 1-vs-Grade 2 |
5.719400E-01 |
| Grade 1-vs-Grade 3 |
6.173200E-01 |
| Grade 1-vs-Grade 4 |
6.527400E-01 |
| Grade 2-vs-Grade 3 |
6.629600E-01 |
| Grade 2-vs-Grade 4 |
2.106100E-02 |
| Grade 3-vs-Grade 4 |
3.947900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.68489666663163E-11 |
| Normal-vs-ccB subtype |
2.791200E-01 |
| ccA subtype-vs-ccB subtype |
1.47509999992579E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.563400E-01 |
| Normal-vs-N1 |
1.566030E-01 |
| N0-vs-N1 |
1.406230E-01 |
|
|
